Bruce Robert Saran, MD | |
915 Old Fern Hill Rd Bldg B Ste 200, West Chester, PA 19380-4269 | |
(610) 696-1230 | |
(610) 696-2341 |
Full Name | Bruce Robert Saran |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 36 Years |
Location | 915 Old Fern Hill Rd Bldg B Ste 200, West Chester, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689674020 | NPI | - | NPPES |
001303228 | Medicaid | PA |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Chester County Eye Care Assoc Pc | 3375437502 | 10 |
News Archive
A recent review in the International Journal of Biological Macromolecules provides a novel overview of 'virosome'-based nanovaccine production, its properties, and its application in viral diseases, emphasizing its importance in SARS-CoV-2 vaccine discovery.
Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment. The "My Answer to Cancer" team of oncologists, bioinformaticians, pathologists and geneticists pledges to "sequence" or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.
Three commonly argued justifications for the persistent discrimination and gender bias that prevent women from rising to leadership positions in the field of pediatric medicine have been debunked by a Drexel University College of Medicine researcher and colleagues in a special article published in the November 2019 issue of the journal Pediatrics.
› Verified 2 days ago
Entity Name | Chester County Eye Care Assoc Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588666200 PECOS PAC ID: 3375437502 Enrollment ID: O20040210000327 |
News Archive
A recent review in the International Journal of Biological Macromolecules provides a novel overview of 'virosome'-based nanovaccine production, its properties, and its application in viral diseases, emphasizing its importance in SARS-CoV-2 vaccine discovery.
Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment. The "My Answer to Cancer" team of oncologists, bioinformaticians, pathologists and geneticists pledges to "sequence" or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.
Three commonly argued justifications for the persistent discrimination and gender bias that prevent women from rising to leadership positions in the field of pediatric medicine have been debunked by a Drexel University College of Medicine researcher and colleagues in a special article published in the November 2019 issue of the journal Pediatrics.
› Verified 2 days ago
Entity Name | University Of Penn - Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
A recent review in the International Journal of Biological Macromolecules provides a novel overview of 'virosome'-based nanovaccine production, its properties, and its application in viral diseases, emphasizing its importance in SARS-CoV-2 vaccine discovery.
Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment. The "My Answer to Cancer" team of oncologists, bioinformaticians, pathologists and geneticists pledges to "sequence" or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.
Three commonly argued justifications for the persistent discrimination and gender bias that prevent women from rising to leadership positions in the field of pediatric medicine have been debunked by a Drexel University College of Medicine researcher and colleagues in a special article published in the November 2019 issue of the journal Pediatrics.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Bruce Robert Saran, MD 915 Old Fern Hill Rd Bldg B Ste 200, West Chester, PA 19380-4269 Ph: (610) 696-1230 | Bruce Robert Saran, MD 915 Old Fern Hill Rd Bldg B Ste 200, West Chester, PA 19380-4269 Ph: (610) 696-1230 |
News Archive
A recent review in the International Journal of Biological Macromolecules provides a novel overview of 'virosome'-based nanovaccine production, its properties, and its application in viral diseases, emphasizing its importance in SARS-CoV-2 vaccine discovery.
Genentech, Inc., a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment. The "My Answer to Cancer" team of oncologists, bioinformaticians, pathologists and geneticists pledges to "sequence" or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.
Three commonly argued justifications for the persistent discrimination and gender bias that prevent women from rising to leadership positions in the field of pediatric medicine have been debunked by a Drexel University College of Medicine researcher and colleagues in a special article published in the November 2019 issue of the journal Pediatrics.
› Verified 2 days ago
Robert P Liss, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 915 Old Fern Hill Rd, Building B Ste 200, West Chester, PA 19380 Phone: 610-696-1230 Fax: 610-918-0803 | |
Samantha Lynn Marek, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 915 Old Fern Hill Rd Ste 200, West Chester, PA 19380 Phone: 610-696-1230 | |
Dr. Gregory Warren Oldham, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd Bldg B Ste 200, West Chester, PA 19380 Phone: 610-696-1230 Fax: 610-696-2341 | |
Holly Clare Simpson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 795 E Marshall St, Ste 103, West Chester, PA 19380 Phone: 610-429-3004 | |
Dr. Cyrus Louis Mineo, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1410 Carroll Brown Way, West Chester, PA 19382 Phone: 215-275-4197 | |
Dr. Richard B Kent, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 845 W Chester Pike, West Chester, PA 19382 Phone: 610-692-8100 Fax: 610-436-4011 | |
Dr. Michael Joseph Ward Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd Bldg B Ste 200, West Chester, PA 19380 Phone: 610-696-1230 Fax: 610-696-2341 |